1. Home
  2. CREX vs IXHL Comparison

CREX vs IXHL Comparison

Compare CREX & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Realities Inc.

CREX

Creative Realities Inc.

N/A

Current Price

$2.93

Market Cap

37.9M

Sector

Technology

ML Signal

N/A

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

N/A

Current Price

$3.80

Market Cap

37.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CREX
IXHL
Founded
N/A
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
37.0M
IPO Year
2015
2024

Fundamental Metrics

Financial Performance
Metric
CREX
IXHL
Price
$2.93
$3.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.6K
81.5K
Earning Date
04-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,437,000.00
$12,000.00
Revenue This Year
$81.98
N/A
Revenue Next Year
$14.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.61
N/A
52 Week Low
$2.21
$0.16
52 Week High
$4.42
$6.39

Technical Indicators

Market Signals
Indicator
CREX
IXHL
Relative Strength Index (RSI) 38.36 N/A
Support Level $2.56 N/A
Resistance Level $3.74 N/A
Average True Range (ATR) 0.23 0.00
MACD -0.00 0.00
Stochastic Oscillator 17.35 0.00

Price Performance

Historical Comparison
CREX
IXHL

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The company operates in one reportable segment, marketing technology solutions. It offers solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks, along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media. Geographically, the company generates maximum revenue from the United States, and the rest from Canada.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: